These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 24183585)
1. Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat. Antonilli L; Togna AR; Sabatini G; Venditti A; Guarcini L; Togna GI; Nicoletti R; Sanasi F; Bianco A; Nencini P Bioorg Med Chem; 2013 Dec; 21(24):7955-63. PubMed ID: 24183585 [TBL] [Abstract][Full Text] [Related]
2. Repeated exposure to codeine alters morphine glucuronidation by affecting UGT gene expression in the rat. Antonilli L; De Carolis L; Brusadin V; Togna AR; Dovizio M; Togna GI; Patrignani P; Nencini P Eur J Pharmacol; 2012 Oct; 693(1-3):7-14. PubMed ID: 23010468 [TBL] [Abstract][Full Text] [Related]
3. Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin. Graziani M; Antonilli L; Togna AR; Brusadin V; Viola S; Togna G; Badiani A; Nencini P Drug Alcohol Depend; 2008 Dec; 98(3):179-84. PubMed ID: 18597954 [TBL] [Abstract][Full Text] [Related]
4. Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat. Antonilli L; Petecchia E; Caprioli D; Badiani A; Nencini P Psychopharmacology (Berl); 2005 Oct; 182(1):58-64. PubMed ID: 15986196 [TBL] [Abstract][Full Text] [Related]
5. Repeated exposures to heroin and/or cadmium alter the rate of formation of morphine glucuronides in the rat. Antonilli L; Suriano C; Paolone G; Badiani A; Nencini P J Pharmacol Exp Ther; 2003 Nov; 307(2):651-60. PubMed ID: 12975487 [TBL] [Abstract][Full Text] [Related]
6. Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids. Morrish GA; Foster DJ; Somogyi AA Br J Clin Pharmacol; 2006 Mar; 61(3):326-35. PubMed ID: 16487227 [TBL] [Abstract][Full Text] [Related]
7. Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat. Meringolo M; Brusadin V; De Luca MT; Montanari C; Antonilli L; Nencini P; Badiani A Psychopharmacology (Berl); 2012 May; 221(2):195-203. PubMed ID: 22016196 [TBL] [Abstract][Full Text] [Related]
8. Design, chemical synthesis, and biological evaluation of thiosaccharide analogues of morphine- and codeine-6-glucuronide. MacDougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR J Med Chem; 2004 Nov; 47(23):5809-15. PubMed ID: 15509180 [TBL] [Abstract][Full Text] [Related]
9. Human liver morphine UDP-glucuronyl transferase enantioselectivity and inhibition by opioid congeners and oxazepam. Wahlström A; Pacifici GM; Lindström B; Hammar L; Rane A Br J Pharmacol; 1988 Jul; 94(3):864-70. PubMed ID: 3140993 [TBL] [Abstract][Full Text] [Related]
10. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244 [TBL] [Abstract][Full Text] [Related]
11. Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7. Stone AN; Mackenzie PI; Galetin A; Houston JB; Miners JO Drug Metab Dispos; 2003 Sep; 31(9):1086-9. PubMed ID: 12920162 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of morphine metabolism by ketamine. Qi X; Evans AM; Wang J; Miners JO; Upton RN; Milne RW Drug Metab Dispos; 2010 May; 38(5):728-31. PubMed ID: 20124399 [TBL] [Abstract][Full Text] [Related]
13. Interaction of ethanol with codeine metabolism in rat hepatocytes: a multicompartmental model. Bodd E; Green MH; Drevon CA; Mørland J Eur J Drug Metab Pharmacokinet; 1986; 11(3):239-43. PubMed ID: 3816880 [TBL] [Abstract][Full Text] [Related]
14. Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors. Thompson CM; Wojno H; Greiner E; May EL; Rice KC; Selley DE J Pharmacol Exp Ther; 2004 Feb; 308(2):547-54. PubMed ID: 14600248 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the hydrolysis rates of morphine-3-glucuronide and morphine-6-glucuronide with acid and beta-glucuronidase. Romberg RW; Lee L J Anal Toxicol; 1995; 19(3):157-62. PubMed ID: 7564293 [TBL] [Abstract][Full Text] [Related]
16. Luminal accumulation of newly synthesized morphine-3-glucuronide in rat liver microsomal vesicles. Révész K; Tóth B; Staines AG; Coughtrie MW; Mandl J; Csala M Biofactors; 2013; 39(3):271-8. PubMed ID: 23281118 [TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors. Yue Q; von Bahr C; Odar-Cederlöf I; Säwe J Pharmacol Toxicol; 1990 Mar; 66(3):221-6. PubMed ID: 2110360 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode. Takeda S; Kitajima Y; Ishii Y; Nishimura Y; Mackenzie PI; Oguri K; Yamada H Drug Metab Dispos; 2006 Aug; 34(8):1277-82. PubMed ID: 16679387 [TBL] [Abstract][Full Text] [Related]
19. Characteristic glucuronidation pattern of physiologic concentration of morphine in rat brain. Nagano E; Yamada H; Oguri K Life Sci; 2000 Oct; 67(20):2453-64. PubMed ID: 11065168 [TBL] [Abstract][Full Text] [Related]
20. Morphine glucuronidation in the rhesus monkey: a comparative in vivo and in vitro study. Rane A; Säwe J; Lindberg B; Svensson JO; Garle M; Erwald R; Jorulf H J Pharmacol Exp Ther; 1984 May; 229(2):571-6. PubMed ID: 6716277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]